| Term 
 | Definition 
 
        | Pumps blood throught the lungs   Right ventricle ---> pulmonary artery (no oxygen) ---> lungs ---> pulmonary vein (oxygen) ---> left ventricle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pumps blood to organs and tissues   Left ventricle --> aorto to organs/tissues --> right atrium (via superior or inferior vena cava) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Time where the heart refills with blood after systole   Tricuspid valve and Mitral valve are open and the Pulmonary valve and Aortic Valve are closed |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Contraction of the heart   Tricuspid and mitral valves are closed and the pulmonary and aortic valves are open |  | 
        |  | 
        
        | Term 
 
        | Non-Renin Creation of Angiotensin II |  | Definition 
 
        | T-P Factor Cathepsin P Tonin |  | 
        |  | 
        
        | Term 
 
        | Non-ACE Synthesis of Angiotensin II |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT I Receptor   Vascular Smooth Muscle Growth |  | Definition 
 
        | (Generally negative consequence)   Increase arteriolar constriction |  | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT I Receptor   CNS |  | Definition 
 
        | (Generally Negative Consequences)   Stimulate to increase cardiac output |  | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT I Receptor   Adrenal Cortex |  | Definition 
 
        | (Generally negative consequences)   Aldosterone stimulation Increase renal sodium reabsorption |  | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT I Receptor   Kidney |  | Definition 
 
        | Generally negative consequences   Increase filtration fraction Increase GFR   (Over a chronic fashion, it can damage the kidneys) |  | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT I Receptor   Brain |  | Definition 
 
        | Generally negative consequences   Increase ADH (antidiuretic hormone) and thirst Increase free water intake |  | 
        |  | 
        
        | Term 
 
        | Consequences of Angiotensin II on AT II Receptor |  | Definition 
 
        | Generally positive consequences   Vasodilation Anti-proliferation Cell differentiation Tissue repair |  | 
        |  | 
        
        | Term 
 
        | Consequences of Aldosterone   Heart |  | Definition 
 
        | Myocardial fibrosis Ventricular arrhythmias Left ventricular hypertrophy (LVH) (enlargening of the heart to decrease the burden on the heart) |  | 
        |  | 
        
        | Term 
 
        | Consequences of Aldosterone   Kidney |  | Definition 
 
        | Sodium retention Magnesium and potassium loss (hyperkalemia)-Specifically with aldosterone blockers |  | 
        |  | 
        
        | Term 
 
        | Consequences of Aldosterone   Vasculature  |  | Definition 
 
        | Hypertension Endothelial dysfunction Inhibits nitric oxide synthesis Prothrombotic |  | 
        |  | 
        
        | Term 
 
        | Consequences of Aldosterone   CNS |  | Definition 
 
        | Sympathetic activation Parasympathetic inhibition |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | May lead to cardiac remodelling, it can lead to blood backing up into lungs, etc. if preload is high   Pressure stretching the ventricle of the heart after atrial contraction and subsequent filling of the ventricle   End diastolic volume (clinically) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tension or pressure used by the chamber of the heart in order to contract and eject blood out of the chamber   End systolic volume (clinically) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SV = End diastolic volume - End systolic volume   What actually got pumped out of the heart |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amount of blood pumped per unit of time   L/min   CO = Heart rate x SV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CO adjusted for BSA   L/min/m2   CI = CO / BSA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fraction of blood ejected by the left ventricle (LV) during contraction or ejection phase of cardiac cycle   EF = SV/EDV (End-Diastolic Volume) x 100%   55-75% is normal |  | 
        |  | 
        
        | Term 
 
        | Mean Arterial Pressure (MAP) |  | Definition 
 
        | Average blood pressure in an individual   MAP = (CO x Systemic vascular resistance [SVR])+Central venous pressure (CVP))   MAP=[(2 x Diastolic pressure)+systolic pressure]/3 |  | 
        |  | 
        
        | Term 
 
        | Pulmonary Capillary Wedge Pressure (PCWP) |  | Definition 
 
        | Under most circumstances provides an accurate estimate of the diastolic filling (preload) of the left heart   During diastole when mitral valve is open, the PCWP reflects LVEDP. LVEDP is an index of left ventricular end-diastolic volume (preload) |  | 
        |  | 
        
        | Term 
 
        | Clinical Assessment of Hemodynamic Parameters   Preload |  | Definition 
 
        | Hepatomegaly (enlarge liver, measure LFTs, palpatate their liver) Jugular venous distention (JVD) Peripheral edema Pulmonary crackles S3 heart sound (seen w/ extreme heart failure and increased preload) Mucous membrane and skin turgor Daily weight |  | 
        |  | 
        
        | Term 
 
        | Clinical Assessment of Hemodynamic Parameters   Afterload |  | Definition 
 
        | Vascular diastolic pressure (decrease) systolic pressure may increase or stay the same   Pulse pressure   Pulses |  | 
        |  | 
        
        | Term 
 
        | Clinical Assessment of Hemodynamic Parameters   Role of the Swan Ganz Catheter |  | Definition 
 
        | Used to measure pulmonary artery pressure, especially in the acute decompensated heart failure patient   Diagrams showing placement of catheter   (Measures pressure) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hardening of the arteries |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Subset of arteriosclerosis   Formation of atheroma (fibrous fatty intimal plaques) in arterial walls |  | 
        |  | 
        
        | Term 
 
        | Ischemic Heart Disease (IHD)   aka Coronary Heart Disease (CHD), Coronary Artery Disease (CAD), Atherosclerotic Vascular Disease (AVD) |  | Definition 
 
        | Ischemia is a lack of oxygen tension at the cellular level and results in loss of high enery phosphates due to disruption of aerobic metabolism Cardiovascular dysfunction occurs at the cellular level due to imbalance between myocardial oxygen supply and myocardial demand, may be transient or permanent (cell death), cellular dysfunction translates into organ dysfunction Etiology: Atherosclerosis |  | 
        |  | 
        
        | Term 
 
        | 4 Main Steps in the Development of Atherosclerosis |  | Definition 
 
        | 1. Endothelial dysfunction   2. Fatty streak formation   3. Fibrous plaque   4. Thrombus formation |  | 
        |  | 
        
        | Term 
 
        | Main Roles of the Endothelium |  | Definition 
 
        | 1. Maintenance of permeability barrier 2. Maintain nonthrombogenic blood-tissue interface (regulate thrombosis, thrombolysis, and platelet adherence) 3. Modulate vascular tone and blood flow 4. Regulate immune and inflammatory reactions (control leukocyte interactions within the vessel wall) 5. Modify lipoproteins in the artery wall 6. Regulate the growth of other cell types, particularly smooth muscle cells |  | 
        |  | 
        
        | Term 
 
        | Definition of Endothelial Dysfunction |  | Definition 
 
        | Diminished ability of the endothelium to regulate vascular tone, clotting, and inflammation |  | 
        |  | 
        
        | Term 
 
        | Causes of Endothelial Dysfunction |  | Definition 
 
        | Age (Not modifiable) Sex (Male>Female) Smoking Family history of CHD (Not modifiable) Dyslipidemia (Increase total cholesterol or LDL, decrease HDL-C) Obesity Diabetes Hypertension Increase homocysteine |  | 
        |  | 
        
        | Term 
 
        | Results of Endothelial Dysfunction |  | Definition 
 
        | Vasoconstriction, pro-thrombotic, and pro-inflammatory   Angiotensin II and endothelin produced as a result of the dysfunctional endothelium resulting in vasoconstriction |  | 
        |  | 
        
        | Term 
 
        | Fatty Streak Formation Process |  | Definition 
 
        | Inside the artery wall monocytes differentiate into macrophages Macrophages engulf lipoproteins (LDL) and then form foam cells Both macrophages and foam cells secrete growth factors and cytokindes resulting in cell proliferation, inflammation, matrix degradation |  | 
        |  | 
        
        | Term 
 
        | Formation of Fibrous Plaque Process |  | Definition 
 
        | Foam cells accumulate and expand in the lining of the artery wall Smooth muscle cells from the middle layer of the artery (media) move into the layer of endothelial cells (intima) Plaque grows and protrudes into the lumen of the blood vessel Fibrous cap of connective tissue overlays the fibrous plaque (prevents vessel from bursting) |  | 
        |  |